Ignite Creation Date:
2024-05-05 @ 11:36 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00088179
Status:
COMPLETED
Last Update Posted:
2018-02-22
First Post:
2004-07-21
Brief Title:
Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass PRIMO-CABG II
Sponsor:
Organization:
Alexion Pharmaceuticals Inc